Last quarter (Q4 2023), Aclaris Therapeutics's total revenue was $17.57M, an increase of 126.62% from the same quarter last year. In Q4, Aclaris Therapeutics's net income was $-1.49M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 30.37M	$ 31.25M	$ 29.75M	$ 6.76M	$ 6.48M	$ 4.23M
Cost of Revenue	$ 4.48M	$ 3.42M	$ -4.02M	$ -4.71M	$ 5.13M	$ 4.05M
Gross Profit	$ 28.36M	$ 27.83M	$ 17.79M	$ 2.05M	$ 1.35M	$ 172.00K
Operating Expense	$ 134.22M	$ 134.22M	$ 102.95M	$ 67.43M	$ 49.87M	$ 92.73M
Operating Income	$ -98.56M	$ -97.36M	$ -85.15M	$ -65.38M	$ -48.52M	$ -92.55M
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	$ -28.78M	$ -28.78M	$ 1.75M	$ 25.48M	$ -2.82M	$ -20.99M
Pretax Income	$ -90.97M	$ -88.85M	$ -86.91M	$ -90.86M	$ -51.34M	$ -113.54M
Tax Provision	$ -367.00K	$ -367.00K	-	-	$ -182.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -73.79M	$ -88.48M	$ -86.91M	$ -90.86M	$ -51.02M	$ -161.35M
Basic EPS	$ -1.27	$ -1.27	$ -1.33	$ -1.60	$ -1.20	$ -3.90
Diluted EPS	$ -1.27	$ -1.27	$ -1.33	$ -1.60	$ -1.20	$ -3.90
Basic Average Shares	$ 279.24M	$ 69.81M	$ 65.21M	$ 56.73M	$ 42.54M	$ 41.32M
Diluted Average Shares	$ 279.24M	$ 69.81M	$ 65.21M	$ 56.73M	$ 42.54M	$ 41.32M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 138.70M	$ 137.64M	$ 98.92M	$ 62.72M	$ 55.00M	$ 96.78M
Net Income From Continuing And Discontinued Operation	$ -88.48M	$ -88.48M	$ -86.91M	$ -90.86M	$ -51.02M	$ -161.35M
Normalized Income	$ -71.32M	$ -106.39M	-	-	$ -48.77M	$ -95.04M
Interest Expense	-	-	-	-	-	-
EBIT	$ -90.97M	$ -88.85M	$ -86.91M	$ -90.86M	$ -48.52M	$ -92.55M
EBITDA	$ -90.11M	$ -87.98M	$ -86.11M	$ -89.94M	$ -47.20M	$ -86.14M

Currency in USD

Aclaris Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing